Director/PDMR Shareholding

Summary by AI BETAClose X

GSK PDMRs completed dividend-reinvestment acquisitions on 13 November 2026 on the NYSE of American Depositary Shares at $50.45 each: Dr Hal Barron acquired 2,259.160 notional ADS (and a separate 72 ADS in a 401(k)), James Ford acquired 53.408 ADS, and Maya Martinez-Davis acquired 81.902 ADS, totaling 2,466.47 ADS for an approximate aggregate value of $124,433.41; purchases were made within executive supplemental savings and 401(k) accounts and appear to be routine dividend reinvestments with limited likely market impact.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings